Quark Pharmaceuticals

Quark Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of RNA interference (RNAi)-based therapeutics. The company was founded in 1994 and is headquartered in Fremont, California, with additional research and development facilities in Israel.

History

Quark Pharmaceuticals was established in 1994 with the aim of developing novel therapeutics based on the newly discovered mechanism of RNA interference. The company was one of the first to recognize the potential of this technology in the field of drug discovery and development.

RNA Interference

RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Quark Pharmaceuticals utilizes this mechanism to develop drugs that can specifically target and silence disease-causing genes.

Products and Pipeline

Quark Pharmaceuticals has a diverse pipeline of product candidates in various stages of clinical development. These include drugs for the treatment of acute kidney injury, delayed graft function, ischemic stroke, and non-arteritic anterior ischemic optic neuropathy.

Partnerships and Collaborations

Quark Pharmaceuticals has established numerous partnerships and collaborations with other biopharmaceutical companies and research institutions. These partnerships have enabled the company to advance its drug discovery and development efforts.

See Also

• Biopharmaceutical
• RNA interference
• Gene expression
• Drug discovery
• Clinical development

This biopharmaceutical related article is a stub. You can help WikiMD by expanding it.